Early surgical or transcatheter aortic valve replacement is not typically recommended for severe aortic stenosis in the ...

Press Release Protembis, a privately-held emerging cardiovascular medical device company, announced today the establishment of a Scientific Advisory Board (SAB) to provide objective advice and ...

The following is a summary of "Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ...

Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial’s two-year ...

The following is a summary of "Transcatheter vs Surgical Aortic Valve Replacement in Lower-Risk Patients: An Updated ...

High-dollar procedures like coronary artery bypass graft (CABG) and transcatheter aortic valve replacement (TAVR) generate billions in hospital revenue. Inflated charges for those procedures, billing ...

The two-year results highlighted the continued superior performance of the Evolut TAVR valve in patients with a small aortic annulus. These results will be followed to assess long-term outcomes.

"The two-year results highlight the continued superior performance of the Evolut TAVR valve in these patients. While we would not yet expect to see a significant difference in the composite ...

Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...

As people age, a buildup of calcium on the aortic valve can make it thicker and stiffer leading to aortic stenosis.

Medtronic (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN, SMART, Trial, the largest international ...